1. Home
  2. AIRG vs CTSO Comparison

AIRG vs CTSO Comparison

Compare AIRG & CTSO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Airgain Inc.

AIRG

Airgain Inc.

HOLD

Current Price

$5.33

Market Cap

47.4M

Sector

Technology

ML Signal

HOLD

Logo Cytosorbents Corporation

CTSO

Cytosorbents Corporation

HOLD

Current Price

$0.59

Market Cap

45.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AIRG
CTSO
Founded
1995
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Medical/Dental Instruments
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
47.4M
45.7M
IPO Year
2016
2008

Fundamental Metrics

Financial Performance
Metric
AIRG
CTSO
Price
$5.33
$0.59
Analyst Decision
Strong Buy
Buy
Analyst Count
4
2
Target Price
$6.25
$5.38
AVG Volume (30 Days)
70.0K
79.4K
Earning Date
05-06-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
31.65
N/A
EPS
N/A
N/A
Revenue
$51,779,000.00
$22,503,908.00
Revenue This Year
$10.31
$12.21
Revenue Next Year
$20.71
$20.37
P/E Ratio
N/A
N/A
Revenue Growth
N/A
48.53
52 Week Low
$3.00
$0.50
52 Week High
$5.85
$1.39

Technical Indicators

Market Signals
Indicator
AIRG
CTSO
Relative Strength Index (RSI) 67.59 35.60
Support Level $3.95 N/A
Resistance Level $5.74 $0.74
Average True Range (ATR) 0.31 0.07
MACD 0.17 -0.01
Stochastic Oscillator 87.70 27.72

Price Performance

Historical Comparison
AIRG
CTSO

About AIRG Airgain Inc.

Airgain Inc is engaged in providing antenna technologies. These technologies can be used to enable performance wireless networking across devices and markets which include connected homes, enterprises, automotive, and the Internet of Things. It also provides solutions to complex radio frequency, engineering challenges, and improving wireless service that require higher throughput, broad coverage footprint, and carrier-grade quality. Geographically, it derives maximum revenue from North America and also has a presence in China and the Rest of the World. The company products include Antenna Plus: Fleet, M2M, IoT Antennas, Carrier-Class Antenna, Embedded Antennas, and External Dipole Antennas.

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

Share on Social Networks: